Home › Diabetes › NCT06784674
Maternal Abdominal Morphology Assessment
Diabetes Prediction During Pregnancy Using Pancreas MRI
Who can join
Ages 18 to 54 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Pregnant women, with a singleton gestation * Age 18 - 54 years at screening * Gestational age \< 14 weeks * Willing to commit to 1 year postpartum follow up * Planning to remain in geographical vicinity of Austin for 1 year after delivery Exclusion Criteria: * Presence of any mechanically or magnetically activated implants * Claustrophobia * Other contraindication for MRI * BMI ≥ 38.0 or maximum width less than 48 cm (necessary to fit within the MRI field of view)
About the study
Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy, in both pregnant mothers and their babies, and find out how they are affected by maternal diabetes.
The MAMA study is a prospective cohort study that will follow women and their babies through pregnancy and one year postpartum. Women aged 18-54, who are under 14 weeks pregnant are being recruited to participate in the MAMA study.
What is being tested
- No intervention (other)
Sponsor: University of Texas at Austin · Participants: 87 · Started: May 6, 2025
Contact the study team
- Jack Virostko, Ph.D. · Phone: 512-495-5126
- Ingrid Harris, MPH · Phone: 512-471-0999
Official record on ClinicalTrials.gov — NCT06784674
Locations in the U.S.
| Texas | Dell Medical School Health Discovery Building, Austin |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.